» Articles » PMID: 8727047

Cytokine Production by a Megakaryocytic Cell Line

Overview
Publisher Springer
Specialties Biology
Cell Biology
Date 1996 Apr 1
PMID 8727047
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The regulation of megakaryopoeisis by cytokines is not yet well understood. It is possible that autocrine loops are established during megakaryocyte growth and differentiation, aiding in the maturation of these cells. The CHRF-288-11 human megakaryoblastic cell line has been examined for cytokine production in growing cells and cells stimulated to differentiate by the addition of phorbol esters. It has been demonstrated that these cells produce RNA corresponding to the interleukins IL-1 alpha, 1 beta, 3, 7, 8, and 11, granulocyte-macrophage colony stimulating factor (GM-CSF), stem cell factor (SCF), transforming growth factor-beta (TGF-beta), tumor necrosis factor-alpha (TNF-alpha), interferon-alpha (INF-alpha), and basic fibroblast growth factor (bFGF). Additionally, RNA corresponding to the receptors for IL-6, GM-CSF, SCF, INF-alpha, beta, bFGF, and monocyte colony stimulating factor (M-CSF) were also expressed by the cells. The receptor for TNF-alpha was detected immunologically. Analysis at the protein level demonstrated that significant amounts of INF-alpha, TNF-alpha, GM-CSF, SCF, IL-1 alpha, and a soluble form of the IL-6 receptor were produced by the cells. Addition of phorbol esters to CHRF-288-11 cells enhances their megakaryocytic phenotype; such treatment also results in increased secretion of INF-alpha, TNF-alpha, and GM-CSF. These results suggest that potential autocrine loops are established during the differentiation of CHRF-288-11 cells, which may alter the capability of the cell to differentiate. These findings are similar to those recently obtained for marrow-derived megakaryocytes (Jiang et al.) suggesting that CHRF-288-11 cells provide a useful model system for the study of cytokine release during megakaryocyte differentiation.

Citing Articles

Proinflammatory microenvironment promotes lymphoma progression in mice with high megakaryocyte and TPO levels.

Au A, Corbin J, Lebois M, Gangatirkar P, Yassinson F, Hyslop S Blood Adv. 2022; 7(8):1560-1571.

PMID: 36075025 PMC: 10139866. DOI: 10.1182/bloodadvances.2022007849.


Large-scale generation of megakaryocytes from human embryonic stem cells using transgene-free and stepwise defined suspension culture conditions.

Zhang B, Wu X, Zi G, He L, Wang S, Chen L Cell Prolif. 2021; 54(4):e13002.

PMID: 33615584 PMC: 8016648. DOI: 10.1111/cpr.13002.


Megakaryocytes as immune cells.

Cunin P, Nigrovic P J Leukoc Biol. 2019; 105(6):1111-1121.

PMID: 30645026 PMC: 6984013. DOI: 10.1002/JLB.MR0718-261RR.


Signal transduction of c-Kit receptor tyrosine kinase in CHRF myeloid leukemia cells.

Scholl S, Kirsch C, Bohmer F, Klinger R J Cancer Res Clin Oncol. 2004; 130(12):711-8.

PMID: 15340843 DOI: 10.1007/s00432-004-0602-7.


Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy.

Limb G, Webster L, Soomro H, Janikoun S, Shilling J Clin Exp Immunol. 1999; 118(2):213-8.

PMID: 10540181 PMC: 1905412. DOI: 10.1046/j.1365-2249.1999.01067.x.

References
1.
Greenberg S, Chandrasekhar C, Golan D, Handin R . Transforming growth factor beta inhibits endomitosis in the Dami human megakaryocytic cell line. Blood. 1990; 76(3):533-7. View

2.
de Sauvage F, Hass P, Spencer S, Malloy B, Gurney A, Spencer S . Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 1994; 369(6481):533-8. DOI: 10.1038/369533a0. View

3.
Li X, Anderson J, Hutzler D, Roodman G . Hemin-induced erythroid differentiation changes the sensitivity of K562 cells to tumor necrosis factor-alpha. Exp Hematol. 1989; 17(11):1059-62. View

4.
Ogura M, Morishima Y, Okumura M, Hotta T, Takamoto S, Ohno R . Functional and morphological differentiation induction of a human megakaryoblastic leukemia cell line (MEG-01s) by phorbol diesters. Blood. 1988; 72(1):49-60. View

5.
Du X, Keller D, Maze R, Williams D . Comparative effects of in vivo treatment using interleukin-11 and stem cell factor on reconstitution in mice after bone marrow transplantation. Blood. 1993; 82(3):1016-22. View